Market Exclusive

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) had its Overweight rating reiterated by Cantor Fitzgerald with a $40.00 price target

Analyst Ratings For ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

Today, Cantor Fitzgerald reiterated its Overweight rating on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) with a price target of $40.00.

There are 6 Buy Ratings, 3 Hold Ratings, 1 Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is Buy with a consensus target price of $35.70 per share, a potential 29.72% upside.

Some recent analyst ratings include

Recent Trading Activity for ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
Shares of ACADIA Pharmaceuticals Inc. closed the previous trading session at 27.52 −0.30 1.08% with 27.51 shares trading hands.

Exit mobile version